-Yusuke Nakamura Researcher Activity Profile

Research Author Detailed Information 

Yusuke Nakamura Publication Rate By Year

Yusuke Nakamura has published 1 paper(s) in 2005, 39 paper(s) in 2007, 11 paper(s) in 2008, for a total of 51 research publications in total.

Yusuke Y Nakamura Author Information

LAST NAME: nakamura

FIRST NAME: yusuke

INITIALS: Y

AFFILIATION:

Papers

Yusuke Nakamura's Publication Record

1. Identification of genes associated with the development of IgA nephropathy: genome-wide screening by SNP markers. Year Published: 2005
Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences.
2. Inhibition of tumor growth through suppression of angiogenesis by brain-specific angiogenesis inhibitor 1 gene transfer in murine renal cell carcinoma. Year Published: 2007
Department of Urology, Iwate Medical University School of Medicine, Morioka 020-8505, Japan.
3. Activation of Holliday junction recognizing protein involved in the chromosomal stability and immortality of cancer cells. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
4. High-resolution SNP and haplotype maps of the human gamma-glutamyl carboxylase gene (GGCX) and association study between polymorphisms in GGCX and the warfarin maintenance dose requirement of the Japanese population. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
5. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
6. Polymorphisms in the 3' UTR in the neurocalcin delta gene affect mRNA stability, and confer susceptibility to diabetic nephropathy. Year Published: 2007
Laboratory for Diabetic Nephropathy, SNP Research Centre, Institute of Physical and Chemical Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa, 230-0045, Japan, smaeda@src.riken.jp.
7. A second generation human haplotype map of over 3.1 million SNPs. Year Published: 2007
The Scripps Research Institute, 10550 North Torrey Pines Road MEM275, La Jolla, California 92037, USA.
8. Genome-wide detection and characterization of positive selection in human populations. Year Published: 2007
Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02139, USA. pardis@broad.mit.edu
9. Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
10. The BioBank Japan Project. Year Published: 2007
Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
11. Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function. Year Published: 2007
Department of Immunogenetics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan. senjusat@gpo.kumamoto-u.ac.jp
12. The lysine 831 of vascular endothelial growth factor receptor 1 is a novel target of methylation by SMYD3. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, The University of Tokyo, Tokyo, Japan.
13. Association of single-nucleotide polymorphisms in MTMR9 gene with obesity. Year Published: 2007
14. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-Ward, Tokyo, Japan.
15. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
16. Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinoma. Year Published: 2007
Department of Biology and Center for Cancer Research, Hong Kong University of Science and Technology, Hong Kong (SAR), People's Republic of China.
17. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
18. The BioBank Japan Project. Year Published: 2007
Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
19. High-resolution SNP and haplotype maps of the human gamma-glutamyl carboxylase gene (GGCX) and association study between polymorphisms in GGCX and the warfarin maintenance dose requirement of the Japanese population. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
20. Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-Ku, Tokyo 108-8639, Japan.
21. Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Shirokanedai 4-6-1 Minato-ku, Tokyo 108-8639, Japan.
22. The BioBank Japan Project. Year Published: 2007
Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
23. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-Ward, Tokyo, Japan.
24. Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinoma. Year Published: 2007
Department of Biology and Center for Cancer Research, Hong Kong University of Science and Technology, Hong Kong (SAR), People's Republic of China.
25. Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
26. Identification of a significant association of a single nucleotide polymorphism in TNXB with systemic lupus erythematosus in a Japanese population. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, the University of Tokyo, 4-6-1 Shirokanedai, Minato, Tokyo, 108-8639, Japan, koichima@ims.u-tokyo.ac.jp.
27. Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function. Year Published: 2007
Department of Immunogenetics, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan. senjusat@gpo.kumamoto-u.ac.jp
28. Multiplex PCR-based real-time invader assay (mPCR-RETINA): a novel SNP-based method for detecting allelic asymmetries within copy number variation regions. Year Published: 2007
Laboratory for Genotyping, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan.
29. Multiplex PCR-based real-time invader assay (mPCR-RETINA): a novel SNP-based method for detecting allelic asymmetries within copy number variation regions. Year Published: 2007
Laboratory for Genotyping, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan. nhosono@src.riken.jp
30. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Year Published: 2007
Laboratory for Gastrointestinal Diseases, SNP Research Center, RIKEN, Yokohama, Kanagawa, 230-0045, Japan. onouchi@src.riken.jp
31. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Year Published: 2007
Laboratory for Gastrointestinal Diseases, SNP Research Center, RIKEN, Yokohama, Kanagawa, 230-0045, Japan. onouchi@src.riken.jp
32. Association of single-nucleotide polymorphisms in MTMR9 gene with obesity. Year Published: 2007
Laboratory for Obesity, SNP Research Center, RIKEN, Kanagawa 230-0045, Japan.
33. Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
34. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Year Published: 2007
Laboratory for Gastrointestinal Diseases, SNP Research Center, RIKEN, Yokohama, Kanagawa, 230-0045, Japan. onouchi@src.riken.jp
35. Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinoma. Year Published: 2007
Department of Biology and Center for Cancer Research, Hong Kong University of Science and Technology, Hong Kong (SAR), People's Republic of China.
36. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-Ward, Tokyo, Japan.
37. A functional SNP in the NKX2.5-binding site of ITPR3 promoter is associated with susceptibility to systemic lupus erythematosus in Japanese population. Year Published: 2008
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, the University of Tokyo, 4-6-1 Shirokanedai, Minato, Tokyo, 108-8639, Japan.
38. Recombination rates of genes expressed in human tissues. Year Published: 2008
39. High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project. Year Published: 2008
40. Recombination rates of genes expressed in human tissues. Year Published: 2008
SNP Research Center, RIKEN, 1-7-22 Suehiro, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.
41. High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project. Year Published: 2008
Department of Gene Diagnostics and Therapeutics, Research Institute, International Medical Center of Japan, Tokyo, Japan. nokato@ri.imcj.go.jp
42. Multiplex PCR-based real-time invader assay (mPCR-RETINA): a novel SNP-based method for detecting allelic asymmetries within copy number variation regions. Year Published: 2007
Laboratory for Genotyping, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), Kanagawa, Japan. nhosono@src.riken.jp
43. Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10. Year Published: 2008
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
44. Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-Ku, Tokyo 108-8639, Japan.
45. Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer. Year Published: 2007
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Shirokanedai 4-6-1 Minato-ku, Tokyo 108-8639, Japan.
46. Enhanced expression of RAD51 associating protein-1 is involved in the growth of intrahepatic cholangiocarcinoma cells. Year Published: 2008
Laboratory of Molecular Medicine, Human Genome Center and Division of Clinical Genome Research, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
47. Polymorphisms in the 3' UTR in the neurocalcin delta gene affect mRNA stability, and confer susceptibility to diabetic nephropathy. Year Published: 2007
Laboratory for Diabetic Nephropathy, SNP Research Centre, Institute of Physical and Chemical Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.
48. Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy. Year Published: 2008
Laboratory for Pharmacogenetics, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), Tokyo 108-8639, Japan.
49. Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia. Year Published: 2008
Laboratory for Pharmacogenetics, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), Tokyo 108-8639, Japan.
50. Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy. Year Published: 2008
Laboratory for Pharmacogenetics, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), Tokyo 108-8639, Japan.
51. Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia. Year Published: 2008
Laboratory for Pharmacogenetics, SNP Research Center, The Institute of Physical and Chemical Research (RIKEN), Tokyo 108-8639, Japan.